pink circular icon of a checklist

Find out if you are eligible to receive help getting started on REZUROCK treatment.

Talk with your health care team about enrolling in Kadmon ASSISTTM.

Kadmon ASSIST logo

Kadmon is committed to helping and supporting people with chronic GVHD, and their caregivers, throughout their treatment journey.

Kadmon ASSIST (Access, Support System and Insurance Services for Treatment) is available to help eligible people

pink circular icon with a white check mark

Determine insurance coverage and costs
for REZUROCK

pink circular icon with a white check mark

Find a savings program they may qualify for

pink circular icon with a white check mark

Have medicine delivered directly by a specialty pharmacy

pink circular icon with a white check mark

Get answers to their questions from a clinical nurse educator about treatment with REZUROCK.

Call 1-844-KADMON1 (523-6661) to learn more about the Kadmon ASSIST support programs designed for people who need treatment for chronic GVHD.

Our Kadmon ASSIST team is available to help you Monday through Friday, 8 am to 8 pm ET.

GVHD, graft-versus-host disease.

aPatient Terms and Conditions: The Kadmon ASSIST Commercial Co-pay Savings Program provides co-pay/coinsurance support for out-of-pocket costs on REZUROCK™ (belumosudil) tablets prescriptions, up to $25,000 per calendar year, limit one 30-day supply per 30 days. This program is not health insurance. This program is for commercially or privately insured patients only; uninsured or cash-paying patients are not eligible. Patients are not eligible if prescriptions are paid, in whole or in part, by any state- or federally funded programs, including, but not limited to, Medicare (including Part D, even in the coverage gap), or where prohibited by law. Kadmon Pharmaceuticals, LLC reserves the right to rescind, revoke or amend this offer without further notice. Other limitations may apply.

USE

REZUROCKTM (belumosudil) is a prescription medicine used to treat adults and children 12 years of age and older with chronic graft-versus-host disease (chronic GVHD) after you have received at least 2 prior treatments (systemic therapy) and they did not work. It is not known if REZUROCK is safe and effective in children less than 12 years old.

IMPORTANT SIDE EFFECT INFORMATION

Before taking REZUROCK, tell your healthcare provider about all of your medical conditions, including if you:

  • have kidney or liver problems.
  • are pregnant or plan to become pregnant. REZUROCK can harm your unborn baby. If you are able to become pregnant, your healthcare provider will do a pregnancy test before starting treatment with REZUROCK. Tell your healthcare provider if you become pregnant or think you may be pregnant during treatment with REZUROCK.
  • - Females who can become pregnant should use effective birth control during treatment with REZUROCK and for at least 1 week after the last dose.
  • - Males with female partners who can become pregnant should use effective birth control during treatment with REZUROCK and for at least 1 week after the last dose.
  • are breastfeeding or plan to breastfeed. It is not known if REZUROCK passes into breast milk. Do not breastfeed during treatment with REZUROCK and for at least 1 week after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. REZUROCK may affect the way other medicines work, and other medicines may affect the way REZUROCK works.

Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

How should I take REZUROCK?

  • Take REZUROCK exactly as your healthcare provider tells you to take it.
  • Do not change your dose or stop taking REZUROCK without first talking to your healthcare provider.
  • Take REZUROCK 1 time a day with a meal.
  • Take REZUROCK at about the same time each day.
  • Swallow REZUROCK tablets whole with a glass of water.
  • Do not cut, crush, or chew REZUROCK tablets.
  • Your healthcare provider will do blood tests to check your liver at least 1 time a month during treatment with REZUROCK.
  • If you miss a dose of REZUROCK, take it as soon as you remember on the same day. Take your next dose of REZUROCK at your regular time on the next day. Do not take extra doses of REZUROCK to make up for a missed dose.
  • If you take too much REZUROCK, call your healthcare provider or go to the nearest hospital emergency room right away.

What are the possible side effects of REZUROCK?

The most common side effects of REZUROCK include:

  • infections
  • tiredness or weakness
  • nausea
  • diarrhea
  • shortness of breath
  • cough
  • swelling
  • bleeding
  • stomach (abdominal) pain
  • muscle or bone pain
  • headache
  • high blood pressure

Your healthcare provider may change your dose of REZUROCK, temporarily stop, or permanently stop treatment with REZUROCK if you have certain side effects.

REZUROCK may affect fertility in males and females. Talk to your healthcare provider if this is a concern for you.

These are not all the possible side effects of REZUROCK. Call your doctor for medical advice about side effects.

Please see full Prescribing Information.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. You may also contact Kadmon Pharmaceuticals, LLC, at 1-877-377-7862 to report side effects.

pink circular icon with plus sign

Use

REZUROCKTM (belumosudil) is a prescription medicine used to treat adults and children 12 years of age and older with chronic graft-versus-host disease (chronic GVHD)

IMPORTANT SIDE EFFECT INFORMATION Before taking REZUROCK, tell your healthcare provider about all of your medical conditions, including if you: pink circular icon with plus sign

Use & Important side effect information

REZUROCKTM (belumosudil) is a prescription medicine used to treat adults and children